Eton Pharmaceuticals Earnings
NASDAQ: ETONHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$0.34
Eton Pharmaceuticals earnings summary
Eton Pharmaceuticals is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $0.34. In its most recent report on Aug 13, 2026 (Q2 2026), ETON posted EPS of $0.35. Revenue for the quarter was $37.6 million.
Across the last 16 reports, ETON shares moved an average of 5.9% (in either direction) in the first trading session after results, rising 13 times and falling 3 times.
Summary generated from market data by MetaCap's automated system. Methodology
ETON earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 13, 2026 | — | $0.35 | — | +7.8% |
| May 14, 2026 | — | $0.05 | — | +7.7% |
| Mar 19, 2026 | — | $0.06 | — | +4.1% |
| Nov 6, 2025 | — | $-0.07 | — | +0.2% |
| Aug 7, 2025 | — | $-0.10 | — | -0.6% |
| May 13, 2025 | — | $-0.06 | — | +4.6% |
| Mar 18, 2025 | — | $-0.02 | — | -8.4% |
| Nov 12, 2024 | — | $0.02 | — | +12.1% |
| Aug 8, 2024 | — | $-0.12 | — | +8.3% |
| May 9, 2024 | — | $-0.03 | — | +5.5% |
| Mar 14, 2024 | — | $-0.10 | — | +2.9% |
| Nov 9, 2023 | — | $-0.02 | — | -7.8% |
| Aug 10, 2023 | — | $0.18 | — | +18.7% |
| May 11, 2023 | — | $-0.10 | — | +1.7% |
| Mar 16, 2023 | — | $209.82 | — | +3.1% |
| Nov 10, 2022 | — | $-0.12 | — | +0.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.